Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sinovac QIV vs Vaxigrip QIV in Pregnant Women
NCT07211152Phase 3Completed
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Oct 2025
- Primary completion
- Jun 2026
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of TetrAnflu in influenza, sponsored by Sinovac Biotech Ltd.. Started Oct 2025; status: completed.
02
Drugs
TetrAnflu
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07211152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07211152.